Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ASPARTIC ACID”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 199 records · Page 11Linked to original sources
PubMedDate not supplied

Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat: II. Tissue distribution.

The distribution of arginine and aspartic acid in brain, testes and liver was studied in rats after the simultaneous oral and intravenous administration of 0.1 mmol of these two amino acids. Exogenous fractions were determined by incorporation of [U-14C]-arginine and [3H]-aspartic acid. A significant increase in the free forms of the two amino acids was observed in all the organs except the liver where aspartic acid decreased after intravenous administration. The oral route induced higher concentrations of arginine in the testes and the brain and of aspartic acid in the liver. The concentrations of aspartic acid were higher in the brain and the testes after intravenous administration. Up to 15% of the dose of arginine administered was found in the liver, most of it bound to protein. Free aspartic acid concentrations underwent two successive increases with return to baseline values between the two phases. The first phase seemed to be due to an accumulation of the amino acid in the organ, followed by binding of the amino acid to the proteins. The second increase seemed to be due to a displacement of the protein bound form towards the free form. The steep rise in cerebral arginine levels, peaking at 30 minutes, may be one of the determining factors governing GH secretion induced by the simultaneous oral administration of aspartic acid and arginine.

Administration, Oral↗
PubMed1986

In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(D)-aspartic acid agonist, in the mammalian striatum.

A potassium-induced, calcium-dependent release of endogenous homocysteic acid (HCA) from rat striatal slices was demonstrated. A precolumn derivatization high-performance liquid chromatography method was developed that allowed quantitative determination of sulfur-containing amino acids at the picomole level. Intracellular recordings from cat caudate neurons during simultaneous microiontophoretic application of drugs and electrical stimulation of the corticocaudate pathway showed that (L)-HCA evoked a depolarization pattern similar to that induced by N-methyl-(D)-aspartic acid (NMDA), and both these depolarizations could be selectively inhibited by a specific NMDA antagonist, (D)-2-amino-7-phosphonoheptanoic acid [(D)-AP-7]. A selective antagonism of (L)-HCA-induced depolarizations by (D)-AP-7 was confirmed in quantitative experiments with the frog hemisected spinal cord in vitro. Small quantities of iontophoretically applied (L)-HCA, but not of quisqualate, potentiated cortically evoked EPSPs in cat caudate neurons. These observations suggest that (L)-HCA might be a candidate as an NMDA-receptor-preferring endogenous transmitter in the caudate nucleus. One possible function for such transmitter systems could be the enhancement of EPSPs.

Animals↗
PubMed1983

Purification and characterization of the heat-stable factors essential for the conversion of lignoceric acid to cerebronic acid and glutamic acid: identification of N-acetyl-L-aspartic acid.

The conversion of lignoceric acid to cerebronic acid, ceramides, cerebrosides, and glutamic acid is catalyzed by a rat brain particulate preparation. The heat-stable factor, prepared from calf cerebellum, together with the heat-labile factor, a pyridine nucleotide, and Mg2+ are essential to all of these metabolic pathways. Our previous work showed that the heat-stable factor is composed of at least two components, HSF-1 and HSF-2, and identified HSF-2 as D-glucose-6-phosphate. In the current investigation, HSF-1 was further purified and found to be N-acetyl-L-aspartic acid. In addition, it was discovered that a third component, HSF-3, is also required for heat-stable factor activity. A reconstituted system composed of N-acetylaspartic acid, glucose-6-phosphate, and HSF-3 fully replaced the heat-stable factor essential for the conversion of lignoceric acid to cerebronic acid and glutamic acid. The reconstituted heat-stable factor did not show the initial time lag always observed with the crude heat-stable factor.

Animals↗
PubMed1990

[Age estimation by amino acid racemization in teeth. A comparison of data for aspartic acid, glutamic acid and alanine].

On the age estimation by the amino acid racemization analysis of dentin, besides the utilization of aspartic acid (Asp) as described in earlier reports, we further studied relationships between the D/L ratios based on glutamic acid (Glu) as well as alanine (Ala) and actual ages. The study was followed up by comparing racemization velocities of the three amino acids under some heating experiments. At four steps (6, 24, 48 and 72 hours) of hydrolysis, the coefficient values of D/L ratio of each amino acid and actual age were calculated as 0.986 to 0.994 for Asp, 0.522 to 0.806 for Glu, and 0.577 to 0.737 for Ala. The data indicate that Asp gives an extremely good result. Glu and Ala do provide reliable D/L ratios, however they are not in proportion to actual ages. Consequently, Glu and Ala seem to be much less suitable for utilization in age estimation. Reaction rate constants (k.yr-1) of racemization of Asp, Glu and Ala in antemortem teeth were 5.3825 x 10(-4), 5.1000 x 10(-5) and 2.3875 x 10(-5), respectively. Those in teeth left drying at 15 degrees C were 2.4850 x 10(-8), 1.9119 x 10(-9), and 1.11450 x 10(-9), respectively. Assuming that the reaction velocity of Asp be 1 in both living and dry states, that of Glu were calculated as 0.09 and 0.08, that of Ala, 0.04 and 0.05, indicating very similar rates. The result confirmed that both Glu and Ala gave considerably slow racemization velocities as compared with Asp.

Age Determination by Teeth↗
PubMed2002

Racemization of aspartic acid in human proteins.

Aspartic acid racemization (AAR) represents one of the major types of non-enzymatic covalent modification that leads to an age-dependent accumulation of abnormal protein in numerous human tissues. In vivo racemization is an autonomic process during the "natural" ageing of proteins, and correlates with the age of long-lived proteins. Consequently AAR can be used as molecular indicator of protein ageing as well as for the identification of permanent proteins that age with the human organism. Although long-living, structural proteins are mainly affected, AAR may be significant on a time scale also relevant to enzymes and signaling proteins. It may result in a loss of protein function due to proteolysis or due to changes in the molecular structure. In vivo racemization may also increase in pathological conditions. AAR has already been discussed as a relevant pathophysiological factor in the pathogenesis of diseases of old age such as atherosclerosis, lung emphysema, presbyopia, cataract, degenerative diseases of cartilage and cerebral age-related dysfunctions. Although the details of the biological consequences of AAR have to be further elucidated, it is evident that AAR plays a role in the molecular biology of ageing.

Aging↗
PubMed1990

Site-directed mutagenesis of rat liver S-adenosylhomocysteinase. Effect of conversion of aspartic acid 244 to glutamic acid on coenzyme binding.

Aspartic acid 244 that occurs at the putative NAD(+)-binding site of rat liver S-adenosylhomocysteinase was replaced by glutamic acid by oligonucleotide-directed mutagenesis. The mutant enzyme was purified to homogeneity as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Gel permeation chromatography showed that the purified mutant enzyme was a tetramer as is the wild-type enzyme. In contrast to the wild-type enzyme, which possesses 1 mol of tightly bound NAD+ per mol of enzyme subunit, the mutant enzyme had only 0.05 mol of NAD+ but contained about 0.6 mol each of NADH and adenine per mol of subunit. The mutant enzyme, after removal of the bound compounds by acid-ammonium sulfate treatment, exhibited S-adenosylhomocysteinase activity when assayed in the presence of NAD+. From the appearance of activity as a function of NAD+ concentration, the enzyme was shown to bind NAD+ with a Kd of 23.0 microM at 25 degrees C, a value greater than 280-fold greater than that of the wild-type enzyme. In the presence of a saturating concentration of NAD+, the mutant enzyme showed apparent Km values for substrates similar to those of the wild-type enzyme. Moderate decreases of 8- and 15-fold were observed in Vmax values for the synthetic and hydrolytic directions, respectively. These results indicate the importance of Asp-244 in binding NAD+, and are consistent with the idea that the region of S-adenosylhomocysteinase from residues 213 to 244 is part of the NAD+ binding site. This region has structural features characteristic of the dinucleotide-binding domains of NAD(+)- and FAD-binding proteins (Ogawa, H., Gomi, T., Mueckler, M. M., Fujioka, M., Backlund, P.S., Jr., Aksamit, R.R., Unson, C.G., and Cantoni, G.L. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 719-723).

Adenosylhomocysteinase↗
PubMed1951

Rate of excretion of N15 after feeding N15-labeled l-aspartic acid in man.

1. l-Aspartic acid labeled with N(15) was fed to one human adult and six infants, and the total N and N(15) were determined in the urine from time to time. 2. The N(15) concentration (or isotopic ratio) of urinary N reached its maximum in the adult about 2 hours and in the infants about 4 hours after feeding, then fell off logarithmically. 3. Assuming that the N of aspartic acid readily entered into equilibrium with other N compounds in the pool, the rate of turnover of the N pool was calculated from the rate of fall of the isotopic ratio of urinary N. This rate of turnover of N was about 4 per cent per hour in the adult and 6 to 12 per cent per hour in the infants. 4. The rate of protein synthesis calculated from the rate of turnover of N was 10 mg. N per kilo per hour in the adult and 18 to 27 mg. N per kilo per hour in the infants, with one exception which showed a higher rate of 52 mg. N per kilo per hour. The size of the metabolic pool of N per kilo in non-growing infants was about the same as that in the adult (0.4 to 0.5 gm.) but it was somewhat larger in growing infants (0.5 to 0.8 gm.).

Adult↗
PubMed1992

[Is aspartic acid regulator of hemopoiesis?].

The effect of aspartic acid on myelopoiesis was examined. A method of bone marrow cultivation was used in diffusion chambers in vivo. We found that injection of 1 x 10(-4) g/kg aspartic acid to intact rats during 5 days resulted in increase of cloning efficiency of granulocyte-progenitor cells by 24 per cent and growth of cluster/colony-forming unit fibroblastic. On the basis of these data we came to the conclusion that aspartic acid acts directly on hemopoietic cells and stromal system.

Animals↗
PubMed2004

The effect of aspartic acid on the binding of transition metals to kaolinite.

The effect of aspartic acid on the adsorption of Pb(II), Cu(II), Zn(II), Co(II), and Mn(II) on kaolinite at 25 degrees C in the presence of 5 mM KNO3 was investigated by means of potentiometric titrations and adsorption measurements over a range of pH and concentration. Data were modeled by extended constant capacitance models. Aspartic acid slightly enhanced the adsorption of Pb(II), Zn(II), and Co(II) at low pH, but inhibited the adsorption of all the metal ions at higher pH. Adsorption of Cu(II) and Co(II) was inhibited strongly. Because aspartic acid is adsorbed only weakly by kaolinite, inhibition of metal ion adsorption depends on the ability of aspartic acid to form complexes with the various metal ions together with the adsorption characteristics of these complexes. In particular suppression of adsorption at high pH arises from competition between surface sites and dissolved aspartate ions for the available metal ions. Cu(II) and Co(II) form complexes with aspartic acid more strongly than the other metals. As these complexes do not adsorb, Cu(II) and Co(II) suffer greater suppression from aspartic acid than the other metals. There was no evidence of adsorption of aspartic acid complexes to the permanently charged kaolinite faces.

Journal Article↗
PubMed1992

Site-directed mutagenesis of glutathione S-transferase YaYa. Important roles of tyrosine 9 and aspartic acid 101 in catalysis.

The roles of tyrosine 9 and aspartic acid 101 in the catalytic mechanism of rat glutathione S-transferase YaYa were studied by site-directed mutagenesis. Replacement of tyrosine 9 with phenylalanine (Y9F), threonine (Y9T), histidine (Y9H), or valine (Y9V) resulted in mutant enzymes with less than 5% catalytic activity of the wild type enzymes. Kinetic studies with purified Y9F and Y9T mutants demonstrated poor catalytic efficiencies which were largely due to a drastic decrease in kcat. The estimated pK alpha values of the sulfhydryl group of glutathione bound to Y9F and Y9T mutant enzymes were 8.5 to 8.7, similar to the chemical reaction, in contrast to the estimated pK alpha value of 6.7 to 6.8 for the glutathione enzyme complex of wild type glutathione S-transferase. These results indicate that tyrosine 9 is directly responsible for the lowering of the pKa of the sulfhydryl group of glutathione, presumably due to the stabilization of the thiolate anion through hydrogen bonding with the hydroxyl group of tyrosine. To examine the role of aspartic acid in the binding of glutathione to YaYa, 4 conserved aspartic acid residues at positions 61, 93, 101, and 157 were changed to glutamic acid and asparagine. All mutant enzymes retained either full or partial activity except D157N, which was virtually inactive. Kinetic studies with four mutant enzymes (D93E, D93N, D101E, and D101N) indicate that only D101N exhibited a 5-fold increase in Km toward glutathione. Also, the binding of this mutant to the affinity column was greatly reduced. These results demonstrate that aspartic acid 101 plays an important role in glutathione interaction to YaYa. The role of aspartic acid 157 in catalysis remains to be determined.

Animals↗
PubMed1969

Capacity of aspartic acid to increase the bacterial count on suspensions of Escherichia coli after freezing.

The addition of 2% Trypticase to a minimal salts-glucose plating medium increased the bacterial count of frozen and thawed suspensions of Escherichia coli 451B cells, even when precautions were taken to remove toxic trace elements from the plating diluent. Hydrolysis of the Trypticase with HCl or H(2)SO(4) reduced its count-increasing activity. Treatment of the H(2)SO(4) hydrolysate with a cation-exchange resin greatly improved its capacity to replace Trypticase. Addition of a mixture of amino acids approximating the composition of casein also increased the plate count when added at a level equivalent to 0.1% casein, but at 2% it depressed the count. Tests of amino acids in the mixture revealed that aspartic acid could replace Trypticase completely as a supplement to the basal medium. When added at a level of 2.5 mm, aspartic acid doubled and occasionally tripled the plate count of a suspension of frozen and thawed cells. Glutamic acid, alanine, and to a lesser extent certain other amino acids also showed a capacity to increase the count. Cysteine was without significant effect. Serine and other amino acids depressed the count. None of the amino acids or other supplements affected the count of suspensions of cells that had not been frozen. The effect of adding aspartic acid, cysteine, or Trypticase to the basal medium on the bacterial count of suspensions of various strains of E. coli, Aerobacter aerogenes, Serratia marcescens, and two species of Pseudomonas after freezing was examined. The response to the supplements was unique for each organism.

Acetates↗
PubMed2001

A study into the role of L-aspartic acid on the metabolism of L-malic acid and D-glucose by Oenococcus oeni.

AIMS: The purpose of this work was to study the effect of L-aspartic acid concentration on bacterial growth, D-glucose fermentation and L-malic acid consumption of Oenococcus oeni NCFB 1707. METHODS AND RESULTS: Bacterial cultures were performed in synthetic media. Bacterial growth, D-glucose fermentation and L-malic acid consumption were reduced when L-aspartic acid concentration became excessive. This inhibitory effect of high concentrations of L-aspartic acid on bacterial growth was also observed with several Oenococcus oeni strains, except O. oeni BL01. The L-aspartic acid inhibitory effect on bacterial growth could be reduced by increasing the concentration of L-glutamic acid. L-glutamic acid transport was found to be competitively inhibited by L-aspartic acid. In addition, an excessive amount of L-aspartic acid modified D-glucose metabolism, with an overproduction of acetic acid and reduced ethanol production. CONCLUSION: Since L-glutamic acid is an essential amino acid for the bacterial strain used, the L-aspartic acid inhibitory effect on bacterial growth could be linked to its involvement in an antagonistic interaction with L-glutamic acid. SIGNIFICANCE AND IMPACT OF THE STUDY: Such antagonistic interactions between amino acids in O. oeni strains could be another explanation for the difficulties of inducing malolactic fermentation in wines.

Aspartic Acid↗
PubMed2004

Extracellular excitatory amino acids increase in the paraventricular nucleus of male rats during sexual activity: main role of N-methyl-d-aspartic acid receptors in erectile function.

The concentrations of glutamic and aspartic acids were measured in the dialysate obtained with vertical microdialysis probes implanted into the paraventricular nucleus of the hypothalamus of sexually potent male rats during sexual activity. Animals showed noncontact erections when put in the presence of, and copulated with, a receptive (ovarietomized oestrogen- and progesterone-primed) female rat. The concentrations of glutamic and aspartic acids in the paraventricular dialysate increased by 37 and 80%, respectively, above baseline values during exposure to the receptive female rat and by 55 and 127%, respectively, during copulation. No changes in the concentrations of glutamic and aspartic acids were detected in the paraventricular dialysate when sexually potent male rats were exposed to nonreceptive (ovariectomized not oestrogen- and progesterone-primed) female rats or when impotent male rats were used. The injection into the paraventricular nucleus of the excitatory amino acid receptor antagonist dizocilpine (5 micro g), a noncompetitive N-methyl-d-aspartic acid receptor antagonist, reduced noncontact erections and significantly impaired copulatory activity. The alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist 6-cyano-7-nitro-quinoxaline-2,3-dione (5 micro g) was also able to impair copulatory activity, but to a much lower extent than dizocilpine. In contrast, (+/-)-2-amino-4-phosphono-butanoic acid, a metabotropic receptor antagonist (5 micro g), was found to be ineffective. These results confirm the involvement of the paraventricular nucleus in the control of erectile function and copulatory behaviour and show that excitatory amino acid concentration increases in the paraventricular nucleus when penile erection occurs in physiological contexts.

6-Cyano-7-nitroquinoxaline-2,3-dione↗
PubMed1985

Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).

Ca2+-dependent cyclic nucleotide phosphodiesterase (Ca2+-PDE) activity was stimulated by poly(L-aspartic acid) but not by poly(L-glutamic acid), poly(L-arginine), poly(L-lysine), and poly(L-proline). This activation was Ca2+ independent and did not further enhance the activation of Ca2+-PDE by Ca2+-calmodulin (CaM). Poly(L-aspartic acid) produced an increase in the Vmax of the phosphodiesterase, associated with a decrease in the apparent Km for the substrate, such being similar to results obtained with Ca2+-CaM. Poly(L-aspartic acid) did not significantly stimulate myosin light chain kinase and other types of cyclic nucleotide phosphodiesterase. CaM antagonists such as N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), trifluoperazine, and chlorpromazine selectively antagonized activation of the enzyme by poly(L-aspartic acid). Kinetic analysis of W-7-induced inhibition of activation of phosphodiesterase by poly(L-aspartic acid) was in a competitive fashion, and the Ki value was 0.19 mM. On the other hand, prenylamine, another type of calmodulin antagonist that binds to CaM at sites different from the W-7 binding sites, did not inhibit the poly(L-aspartic acid)-induced activation of Ca2+-dependent cyclic nucleotide phosphodiesterase. These results imply that poly(L-aspartic acid) is a calcium-independent activator of Ca2+-dependent phosphodiesterase and that aspartic acids in the CaM molecule may play an important role in the activation of Ca2+-PDE.

2',3'-Cyclic-Nucleotide Phosphodiesterases↗
PubMed1990

Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.

The ras proto-oncogenes encode membrane bound proteins (p21) which are structurally distinct from the proteins encoded by the activated transforming ras genes. These activated ras genes have been identified in various human tumors as well as their preneoplastic lesions such as colorectal tumors (20-40%), pancreatic carcinomas (95%), lung carcinomas (20-30%), myelodysplasia (40%) and acute myeloid leukemia (30%). The activation of ras p21 is due to amino acid substitutions at positions 12, 13 or 61 of the p21 protein. This report describes two monoclonal antibodies designated D129 and D146 raised against a synthetic peptide corresponding to amino acids 5-16 of ras p21 activated by the substitution of aspartic acid for glycine at position 13. D129 and D146 react specifically with the peptide with the aspartic acid substitution at position 13, but not with the peptide with valine at position 13 or the peptide containing the normal glycine at position 13. Western blot analysis demonstrates that D129 and D146 react specifically with p21 extracted from transformed NIH3T3 fibroblast lines containing aspartic acid at position 13. These studies also demonstrate that D146 is able to detect the activated p21 with aspartic acid at position 13 that is shed into the culture media. Studies demonstrate that MAb D146 specifically immunoprecipitates the cellular p21 with aspartic acid at position 13 from transformed NIH3T3 cells, whereas D129 cannot immunoprecipitate the activated p21. Using a sandwich ELISA format, D146 is able to detect the p21 with position 13 aspartic acid from cell extracts and culture fluids. The ability of D146 to function in the ELISA format raises the possibility that this assay maybe a quick and effective way of determining the presence of activated p21 with aspartic acid at position 13 in human fluids and tissues.

Animals↗
PubMed2004

[The study of adsorption of L-aspartic acid on silver sol by surface-enhanced Raman scattering].

The adsorption state and the characteristics of L-aspartic acid adsorbed on silver sol were studied by the Surface-Enhanced Raman Scattering (SERS) method. Strong Raman signals were detected in the experiments. The results suggested that L-aspartic acid adsorbed on the silver surfaces through carboxyl and nitrogen atoms since the signals were mainly due to the carboxyl and the nitrogen of the molecule of L-aspartic acid. The adsorption of carboxyl on the silver surfaces is chemical adsorption, which is based on the mechanism of charge-transfer, while the adsorption of nitrogen on the silver surfaces is physical type, which is due to the electromagnetic mechanism. The intensity of surface-enhanced Raman scattering of L-aspartic acid adsorbed on silver surface was also analyzed, and it was found that the intensity of surface-enhance Raman scattering will change with different concentrations of L-aspartic acid adsorbed on the silver surfaces. The intensity will reach the top value when the concentration of L-aspartic acid was 10(-3) mol x L(-1). When the concentration of L-aspartic acid decreased to 10(-4) mol x L(-1), the intensity of surface-enhanced Raman scattering became a little weaker than that with 10(-3) mol x L(-1). With further decrease in the concentration of L-aspartic acid, the intensity of surface-enhanced Raman scattering also decreased gradually. When the concentration of L-aspartic acid decreased to 10(-6) mol x L(-1), the intensity of surface-enhanced Raman scattering was very low. The above study will be helpful to the further study of peptide and other complex biological systems.

Adsorption↗